Tag: Bridget Phillipson

The below Parliamentary question was asked by Bridget Phillipson on 2015-10-27.

To ask the Secretary of State for Transport, if his Department will examine evidence from Scotland on the effects of a lower drink-drive limit; and if he will make it his policy to equalise the limit in England.

Andrew Jones

Tackling drink driving is a priority for this Government and we have continued to focus on tough enforcement. In April 2015 legislation was introduced through the De-Regulation Act which removed the automatic right for drivers who fail a breathalyser test to demand a blood or urine test. This has denied people the chance to sober up while waiting for the test to be taken. Also, ‘High Risk Offenders’ are now required to prove that they are no longer alcohol-dependent before being allowed to drive.

I would be interested to see a robust and comprehensive evaluation of the change to the Scottish drink drive limit.

The below Parliamentary question was asked by Bridget Phillipson on 2015-10-26.

To ask the Secretary of State for Transport, if his Department will give consideration to introducing the testing of (a) night-time and (b) motorway driving as mandatory components of the driving test.

Andrew Jones

Current legislation requires the eyesight element of the practical driving test to be conducted in good daylight and prohibits learner drivers from motorways. The learning to drive and testing processes are, however, kept under review. The Driver and Vehicle Standards Agency (DVSA) is currently trialling a series of potential changes aimed at encouraging learner drivers to obtain a wider range of driving experience prior to the practical driving test. This will include driving on roads which require a higher speed and other varying traffic situations. DVSA is also developing clips that depict hazards related to driving at night for inclusion in the hazard perception element of the theory test.

The below Parliamentary question was asked by Bridget Phillipson on 2015-10-09.

To ask the Secretary of State for Business, Innovation and Skills, how many apprenticeships are available in the North East; and how many applicants for such apprenticeships from disadvantaged backgrounds (a) secured and (b) completed apprenticeships in each of the last 10 years.

Nick Boles

Information on the number of apprenticeship starts (first link) and achievements (second link) in the North East is published online at the FE Data Library:

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/438150/apprenticeships-starts-by-geography-learner-demographics-and-sector-subject-area.xls

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/378238/apprenticeships-achievements-by-geography-learner-demographics-and-sector-subject-area.xls

We do not centrally collect information on the number of apprenticeship applicants from disadvantaged backgrounds who secure and complete an apprenticeship.

“

The below Parliamentary question was asked by Bridget Phillipson on 2015-10-09.

To ask the Secretary of State for Health, what measures his Department is taking to improve social care quality.

Alistair Burt

I refer the hon. Member to the reply I gave on 13 October 2015 to Question 10428.

“

The below Parliamentary question was asked by Bridget Phillipson on 2015-10-09.

To ask the Secretary of State for Health, what his Department’s policy is on making the drug Keyruda available for cancer treatment in the NHS.

George Freeman

Pembrolizumab (Keytruda) for the treatment of advanced melanoma, which has spread or cannot be removed by surgery and has progressed after other treatments, is the first drug to be given a positive scientific opinion through the Early Access to Medicines Scheme (EAMS). NHS England has undertaken to fund the use of EAMS products routinely within 30 days of National Institute for Health and Care Excellence (NICE) guidance being published.

NICE published final guidance on pembrolizumab on 7 October 2015 which recommends its use for the treatment of advanced melanoma after disease progression with ipilimumab.

NICE is also appraising pembrolizumab for advanced melanoma that has not been previously treated with ipilimumab and published final draft guidance which recommends its use on 9 October 2015. NICE’s final guidance is expected to be published in November 2015.

The below Parliamentary question was asked by Bridget Phillipson on 2014-06-25.

To ask the Secretary of State for Justice, what his strategy is for supporting victims of crime.

Damian Green

The Government is committed to providing more support than ever to victims of crime, and giving them a louder voice in the criminal justice system. We have implemented a new Victims’ Code that tells people what to expect at every stage of the process. We’re aiming to spend up to £100 million – more than ever before – to support victims to cope and, where possible, recover from the effects of crime.

The below Parliamentary question was asked by Bridget Phillipson on 2014-06-16.

To ask the Secretary of State for Defence, if he will place a copy of 2014DIN05-012 on JSP 441 – The Defence Records Management Policy and Procedures: Publication of Version 4:3 in the Library.

Dr Andrew Murrison

A copy of the Defence Instruction Notice 2014-DIN05-012 regarding JSP 441 will be placed in the Library of the House.

The below Parliamentary question was asked by Bridget Phillipson on 2014-06-04.

To ask the Secretary of State for Defence, how many staff in his Department were in receipt of excess fare allowance in each year for which figures are available.

Anna Soubry

The following table provides the numbers of Ministry of Defence civilian staff in receipt of Excess Fares Allowance (EFA) by financial year, from the earliest date that figures are available;